Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

OMEROS CORPORATION

(OMER)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société OMEROS CORPORATION
08/03OMEROS CORPORATION : to Announce Second Quarter Financial Results on August 9, 2..
BU
06/16OMEROS : Form 8-K)
PU
06/16OMEROS CORP : Submission of Matters to a Vote of Security Holders, Financial Sta..
AQ
06/15OMEROS' : Narsoplimab pivotal trial data shared in oral presentation at 2021 ann..
AQ
06/14OMEROS : rsquo; Narsoplimab Pivotal Trial Data Shared in Oral Presentation at 20..
BU
06/10OMEROS : Announces Publication Detailing the Mechanism of Action of PDE7 In Nico..
BU
06/09OMEROS : to Present at the BofA 2021 Napa BioPharma Virtual Conference
BU
06/09OMEROS : Announces Preliminary Results from Phase 1 Clinical Trial of OMS906
BU
06/01SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investor..
PR
05/31OMEROS : Announces preliminary results from additional critically ill covid-19 p..
AQ
05/28OMEROS : Announces Preliminary Results from Additional Critically Ill COVID-19 P..
BU
05/20OMEROS CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
05/20OMEROS : Announces Extension of FDA Review Period for Narsoplimab in HSCT-TMA
BU
05/14OMEROS' : Narsoplimab pivotal trial data to be shared as an oral presentation at..
AQ
05/13OMEROS : rsquo; Narsoplimab Pivotal Trial Data to Be Shared as an Oral Presentat..
BU
05/12OMEROS : Reports First Quarter 2021 Financial Results (Form 8-K)
PU
05/10OMEROS : Q1 Earnings Snapshot
AQ
05/10OMEROS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
05/10OMEROS CORP : Results of Operations and Financial Condition, Financial Statement..
AQ
05/10OMEROS CORPORATION : Reports First Quarter 2021 Financial Results
BU
05/05OMEROS CORPORATION : to Announce First Quarter Financial Results on May 10, 2021
BU
05/04OMEROS CORPORATION : Announces Approval of ICD-10 Codes for HSCT-TMA Diagnosis a..
BU
03/23OMEROS : and Quantum Leap Announce First Patients Dosed with Narsoplimab in the ..
BU
03/01OMEROS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
03/01OMEROS : 4Q Earnings Snapshot
AQ
03/01OMEROS CORP : Results of Operations and Financial Condition, Financial Statement..
AQ
03/01OMEROS CORPORATION : Reports Fourth Quarter and Year-End 2020 Financial Results
BU
02/25OMEROS CORPORATION : to Announce Fourth Quarter and Year-End Financial Results o..
BU
01/26OMEROS : Hires Nadia Dac as Chief Commercial Officer
BU
01/20OMEROS CORPORATION : - Biologics License Application for Narsoplimab in HSCT-TMA..
AQ
01/19OMEROS : Biologics License Application for Narsoplimab in HSCT-TMA Accepted for ..
BU
01/11OMEROS : to Present at the 39th Annual J.P. Morgan Healthcare Conference
BU
2020OMEROS : CMS Confirms Continued Separate Payment for Omeros FDA-Approved OMIDRIA..
AQ
2020OMEROS : CMS Confirms Continued Separate Payment for Omeros' FDA-Approved OMIDRI..
BU
2020OMEROS : Submits its Biologics License Application to U.S. FDA for Narsoplimab i..
AQ
2020OMEROS : Submits its Biologics License Application to U.S. FDA for Narsoplimab i..
BU
2020OMEROS : 3Q Earnings Snapshot
AQ
2020OMEROS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
2020OMEROS CORP : Results of Operations and Financial Condition, Financial Statement..
AQ
2020OMEROS CORPORATION : Reports Third Quarter 2020 Financial Results
BU
2020OMEROS CORPORATION : to Announce Third Quarter Financial Results on November 9, ..
BU
2020OMEROS : Participates in Investor Conference Focused on COVID-19 Therapeutics in..
AQ
2020OMEROS : Participates in Investor Conference Focused on COVID-19 Therapeutics in..
BU
2020OMEROS : Reports Final Efficacy and Safety Data from the Narsoplimab Pivotal Tri..
AQ
2020OMEROS : Reports Final Efficacy and Safety Data from the Narsoplimab Pivotal Tri..
BU
2020OMEROS : OMS906 Data Presented at Complement-based Drug Development Summit
AQ
2020OMEROS : Schedules Webcast to Present Final Efficacy Results from Narsoplimab BL..
AQ
2020OMEROS : rsquo; OMS906 Data Presented at Complement-based Drug Development Summi..
BU
2020OMEROS : Schedules Webcast to Present Final Efficacy Results from Narsoplimab BL..
BU
2020OMEROS : Provides Update on Separate Payment for OMIDRIA in the ASCs
AQ
2020OMEROS : Provides Update on Separate Payment for OMIDRIA® in the ASCs
BU
2020OMEROS : to Present at the Cantor Virtual Global Healthcare Conference
AQ
2020OMEROS : to Present at the Cantor Virtual Global Healthcare Conference
BU
2020OMEROS CORPORATION : - Expert Panel Points to Central Role of Endothelial Injury..
AQ
2020OMEROS : Expert Panel Points to Central Role of Endothelial Injury and Lectin Pa..
BU
2020OMEROS' : Investigational New Drug Application for OMS906 Cleared by FDA
AQ
2020OMEROS : rsquo; Investigational New Drug Application for OMS906 Cleared by FDA
BU
2020OMEROS CORP : Entry into a Material Definitive Agreement, Other Events, Financia..
AQ
2020OMEROS : Announces Pricing of Public Offerings
BU
2020OMEROS : 2Q Earnings Snapshot
AQ
2020OMEROS : Announces Proposed Public Offerings of Common Stock and Convertible Sen..
BU
2020OMEROS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
2020OMEROS CORP : Results of Operations and Financial Condition, Financial Statement..
AQ
2020OMEROS CORPORATION : Reports Second Quarter 2020 Financial Results
BU
2020OMEROS CORPORATION : Reports Recovery and Survival of All Patients in Study Eval..
BU
2020OMEROS : Narsoplimab Pivotal Trial Data to be shared as an Oral Presentation at ..
AQ
2020OMEROS : rsquo; Narsoplimab Pivotal Trial Data Shared in Oral Presentation at An..
BU
2020OMEROS CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2020OMEROS : rsquo; Narsoplimab Pivotal Trial Data to be Shared as an Oral Presentat..
BU
2020OMEROS CORPORATION : Announces Presentation of Narsoplimab Pivotal Trial Data at..
BU
2020OMEROS : 1Q Earnings Snapshot
AQ
2020OMEROS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
2020OMEROS CORP : Results of Operations and Financial Condition, Financial Statement..
AQ
2020OMEROS CORPORATION : Reports First Quarter 2020 Financial Results
BU
2020OMEROS CORPORATION : to Announce First Quarter Financial Results on May 11, 2020
BU
1  2  3  4  5  6  7Next
Upcoming event on OMEROS CORPORATION